Myomo (MYO) Return on Capital Employed (2017 - 2025)
Myomo's (MYO) quarterly Return on Capital Employed came in at 43.7% in Q3 2025, up 4696.0% YoY from 0.91% in Q3 2024, and down 31.44% on a QoQ basis from 33.24% in Q2 2025.
Myomo (MYO) Return on Capital Employed (2017 - 2025) Analysis & Trends
Myomo (MYO) has 9 years of Return on Capital Employed data on file, last reported at 43.7% in Q3 2025.
- Quarterly Return on Capital Employed rose 4696.0% year-over-year to 43.7% in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 43.7% (up 4696.0% YoY) and the FY2024 annual result came in at 34.03%, up 8536.0% from the prior year.
- Return on Capital Employed retreated to 43.7% in Q3 2025, from 33.24% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 19.54% in Q1 2025 to a low of 141.35% in Q4 2022.
- A 5-year average of 78.44% and a median of 79.6% in 2023 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2021 — Return on Capital Employed jumped 8885 bps — and 2022, when it slumped 7050 bps.
- Tracing MYO's Return on Capital Employed over 5 years: stood at 70.84% in 2021, then sank by 100 bps to 141.35% in 2022, then surged by 44 bps to 79.6% in 2023, then soared by 59 bps to 32.48% in 2024, then tumbled by 35 bps to 43.7% in 2025.
- The last three Return on Capital Employed figures came in at 43.7% (Q3 2025), 33.24% (Q2 2025), and 19.54% (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 12.08% |
| 10 | Myomo | 67.26 Mn | 48.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -43.70% |
| Jun 30, 2025 | -33.24% |
| Mar 31, 2025 | -19.54% |
| Dec 31, 2024 | -32.48% |
| Sep 30, 2024 | -90.65% |
| Jun 30, 2024 | -95.66% |
| Mar 31, 2024 | -94.54% |
| Dec 31, 2023 | -79.60% |
| Sep 30, 2023 | -85.42% |
| Jun 30, 2023 | -96.11% |
| Mar 31, 2023 | -132.44% |
| Dec 31, 2022 | -141.35% |
| Sep 30, 2022 | -120.69% |
| Jun 30, 2022 | -83.74% |
| Mar 31, 2022 | -70.04% |
| Dec 31, 2021 | -70.84% |
| Sep 30, 2021 | -66.72% |
| Jun 30, 2021 | -60.66% |
| Mar 31, 2021 | -72.98% |
| Dec 31, 2020 | -86.35% |